News and Announcements
MEME Australian Share Fund Shares Factsheet and Performance Review
- Published May 31, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
MEME Australia Share Fund has recently reviewed for May 2017. The month of May saw a return to form for the fund with our performance of +0.66% outperforming the broad markets return of -2.58% by a significant +3.24%. Particularly pleasing was that the fund out preformed all market cap segments, with the ASX20 returning -4.83%, ASX100 returning -2.82%, Small Ordinaries returning -2.06% and Emerging Companies (ASX300+) returning -1.05%. This most recent result brings the Fund returns since inception to +12.34 per annum, comfortably ahead of the market’s +9.57%.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
